TrialSpark is a technology-driven pharma company that runs end-to-end clinical trials, focused on bringing new treatments to patients faster and more efficiently. TrialSpark has built a technology platform that optimizes all aspects of a clinical trial, enabling more efficient trial design, faster trial completion, and higher trial data quality.
Market
Clinical Trials
Location
New York,
NY,
USA
Coinvestors
ArrowMark Partners, Casdin Capital, Dragoneer Investment Group, Felicis Ventures, John Doerr, Lachy Groom, Sam Altman, Sound Ventures, Spark Capital, Thrive Capital